Pharmaceuticals

Compounding Pharmacy Market, Share & Trends Analysis Report, By Products (Topical, Oral, Rectal, Nasal, Ophthalmic), By Therapeutic Areas, By Route of Administration, By Sterility Type, By End User, By Compounding Type, By Region, and Segment Forecasts, 2024-2031

The Compounding Pharmacy Market Size is valued at USD 14.79 Bn in 2023 and is predicted to reach USD 26.38 Bn by the year 2031 at an 7.6% CAGR during the forecast period for 2024-2031. Compounding is the creation of a pharmaceutical preparation of a drug by a licensed pharmacist to meet the unique needs of an individual patient, whether human or animal when a commercially available drug does not suffice. This may be necessary when a patient ca...

Report ID: 2678  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 165

3D Printed Medical Sensor and Biosensor Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation Technology, Inkjet-based Technology, Syringe-based Technology, Laser-based Technology, Others), By Material, By Region, And By Segment Forecasts, 2024-2031

The 3D Printed Medical Sensor and Biosensor Market is expected to grow at a 12% CAGR during the forecast period for 2024-2031.  3D printed medical sensors and biosensors, which are made utilizing cutting-edge production techniques, are used to create a variety of medical testing and tracking products. The urgent need for unique production technologies in the medical industry to boost output and reduce costs will help the overall company's...

Report ID: 1321  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 170

3D Protein Structure Analysis Market Size, Share & Trends Analysis Report By Product (Consumables, Equipment, Computational Software), By End-User (Biopharmaceutical Company, Academic and Research Institute, Other), End User, By Region, And By Segment Forecasts, 2024-2031

The 3D Protein Structure Analysis Market Size is valued at 1267.17 Million in 2023 and is predicted to reach 2,945.23 Million by the year 2031 at a 11.19% CAGR during the forecast period for 2024-2031 Key Industry Insights & Findings from the Report: The increasing need for personalized medicine, which relies heavily on understanding individual protein structures to tailor treatments, is propelling the market. The gro...

Report ID: 1373  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 180

Antibody and Recombinant Protein CDMO Market Size, Share & Trends Analysis Report By Type (Antibody CDMO, Recombinant Protein CDMO), By Application (Pharmaceutical Company, Biotechnology Company, Generic Company), By Region, And By Segment Forecasts, 2024-2031

The Antibody and Recombinant Protein CDMO Market Size is valued at USD 16.2 billion in 2023 and is predicted to reach USD 36.1 billion by the year 2031 at a 10.8% CAGR during the forecast period for 2024-2031. The antibody and recombinant protein CDMO (Contract Development and Manufacturing Organization) market is a subset of the biopharmaceutical industry that is focused on the development as well as production of recombinant proteins and ant...

Report ID: 2664  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 170

Fecal Calprotectin Test Market Size, Share & Trends Analysis Report By Patient Type (Adult and Pediatric), By Assay Type (ELISA [Enzyme Linked Immunosorbent Assay], Enzyme Fluoroimmunoassay, and Quantitative Immune-chromatography)), By Indication, By End-user, By Region, Forecasts, 2024-2031

The Fecal Calprotectin Test Market Size was valued at USD 140.2 Mn in 2023 and is predicted to reach USD 280.5 Mn by 2031 at a 9.17% CAGR during the forecast period for 2024-2031. Fecal calprotectin testing can identify gastrointestinal inflammation. A protein called calprotectin is secreted by white blood cells when inflammation occurs. Several factors drive the global fecal calprotectin test industry forward, including healthcare providers' ...

Report ID: 2659  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 168

CD Antigen Cancer Therapy Market Size, Share & Trends Analysis Report By Type of CD Antigen Targeted (CD19, CD20, CD30, CD33, CD38, CD70), By Therapy Type [Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), Chimeric Antigen Receptor (CAR) T-cell Therapy, Bi-specific T-cell Engagers (BiTEs), Radioimmunotherapy, Immunotoxins], By Cancer Type, By End User, By Region, And By Segment Forecasts, 2024-2031

The CD Antigen Cancer Therapy Market Size is valued at USD 26.2 Bn in 2023 and is predicted to reach USD 41.8 Bn by 2031 at a 6.21% CAGR during the forecast period for 2024-2031. CD antigen cancer therapy is a tailored treatment method that targets specific proteins on the surface of cancer cells. These proteins are called CD antigens. An increasing number of malignancies are being diagnosed on a global scale, which is driving the CD antigen c...

Report ID: 2644  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 170

Cancer-focused Genetic Testing Service Market Size, Share & Trends Analysis Report By Test Type (Chromosome Testing, DNA Testing, Direct DNA Testing, Indirect DNA Testing, Biochemical Genetic Testing), By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Bladder Cancer, Kidney Cancer, Other), By Service Provider, By Region, And By Segment Forecasts, 2024-2031

The Cancer-focused Genetic Testing Service Market Size is valued at USD 7.82 billion in 2023 and is predicted to reach USD 14.41 billion by the year 2031 at an 8.2% CAGR during the forecast period for 2024-2031. Genetic testing services that specifically target cancer are an essential part of contemporary oncology, providing substantial advantages in evaluating risk, preventing the disease, and tailoring treatment to individual patients. Throu...

Report ID: 2622  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 175

Solid Organ Transplantation (SOT) Market Size, Share & Trends Analysis Report By Organ (Renal, Liver, Heart, Lung, Pancreatic, Intestinal Transplantation, Others), By Treatment (Immunosuppressive, Monoclonal Antibodies, Others), By End User (Hospitals, Specialty Centers, Homecare, Others), By Region, And By Segment Forecasts, 2024-2031

The Solid Organ Transplantation (SOT) Market Size is predicted to grow at a 6.91% CAGR during the forecast period for 2024-2031. The solid organ transplantation (SOT) market encompasses all aspects related to organ transplants, from surgeries and immunosuppressive medications to medical devices and healthcare services. Solid organ transplantation works with an advantage for patients suffering from end-stage kidney, pancreas, small intestine, h...

Report ID: 2625  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 175

MedTech CMO Market Size, Share & Trends Analysis Distribution by Product and Services (Design, Manufacturing, Sterilization and Packaging), Manufacturing Techniques (Injection Molding, Cutting and Machining, Extrusion, Blow Molding), End-users and Segment Forecasts, 2024-2031

The MedTech CMO Market Size is predicted to grow at an 12.18% CAGR during the forecast period for 2024-2031. MedTech CMOs are specialized organizations providing contract manufacturing services for medical devices, encompassing design, development, production, and packaging. They possess the necessary expertise, facilities, and regulatory compliance to produce a wide array of medical technologies, including surgical instruments, diagnostic too...

Report ID: 2627  |  

Delivery: Immediate  |  

Published: August 2024   |  

No. of Pages: 170

Base Editing Market Size, Share & Trends Analysis Report by Product (Platform, Reagents & Kits, Plasmids, Base Editing Libraries), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), By Region, And By Segment Forecasts, 2024-2031

The Base Editing Market Size is valued at USD 273.1 Mn in 2023 and is predicted to reach USD 904.8 Mn by the year 2031 at a 16.4% CAGR during the forecast period for 2024-2031. Base editing refers to the methods and instruments that radically alter an existing biological genomic instruction by making incredibly precise modifications to DNA sequences of genes. The scientific and medical sectors are developing associations to pool data and asset...

Report ID: 2619  |  

Delivery: Immediate  |  

Published: July 2024   |  

No. of Pages: 180